AU2001297949A1 - Mammalian alpha-helical protein-53 - Google Patents

Mammalian alpha-helical protein-53

Info

Publication number
AU2001297949A1
AU2001297949A1 AU2001297949A AU2001297949A AU2001297949A1 AU 2001297949 A1 AU2001297949 A1 AU 2001297949A1 AU 2001297949 A AU2001297949 A AU 2001297949A AU 2001297949 A AU2001297949 A AU 2001297949A AU 2001297949 A1 AU2001297949 A1 AU 2001297949A1
Authority
AU
Australia
Prior art keywords
helical protein
mammalian alpha
mammalian
alpha
helical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001297949A
Inventor
Zeren Gao
Kimberly E. Shoemaker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zymogenetics Inc
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of AU2001297949A1 publication Critical patent/AU2001297949A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001297949A 2000-11-17 2001-11-14 Mammalian alpha-helical protein-53 Abandoned AU2001297949A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24968600P 2000-11-17 2000-11-17
US60/249,686 2000-11-17
PCT/US2001/043884 WO2002079248A2 (en) 2000-11-17 2001-11-14 Mammalian alpha-helical protein-53

Publications (1)

Publication Number Publication Date
AU2001297949A1 true AU2001297949A1 (en) 2002-10-15

Family

ID=22944557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001297949A Abandoned AU2001297949A1 (en) 2000-11-17 2001-11-14 Mammalian alpha-helical protein-53

Country Status (5)

Country Link
EP (1) EP1355937A2 (en)
JP (1) JP2004526446A (en)
AU (1) AU2001297949A1 (en)
CA (1) CA2429265A1 (en)
WO (1) WO2002079248A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1290217A2 (en) * 2000-02-04 2003-03-12 Aeomica, Inc. Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
AU2001243693A1 (en) * 2000-03-17 2001-10-03 Zymogenetics Inc. Helical protein zalpha51

Also Published As

Publication number Publication date
WO2002079248A2 (en) 2002-10-10
CA2429265A1 (en) 2002-10-10
JP2004526446A (en) 2004-09-02
WO2002079248A3 (en) 2003-09-04
EP1355937A2 (en) 2003-10-29

Similar Documents

Publication Publication Date Title
EP1130098A3 (en) Mammalian osteoregulins
AU1290001A (en) Antibodies
AU2001271589A1 (en) Mammalian secreted proteins
AU4976400A (en) Glass composition
AU4935000A (en) Antibodies
AU4127699A (en) Z-stud structural member
AU4431000A (en) Novel use
AU2001265089A1 (en) Rc-timer scheme
AU2678800A (en) Modified calycins
AU6045900A (en) Interaction-activated proteins
AU2002220553A1 (en) Bioreactor
AU2001281965A1 (en) Novel 6-phenylphenanthridines
AU2001247558A1 (en) Mammalian two-hybrid system
AU2001284418A1 (en) Novel polypeptide
AU5706000A (en) Useful polypeptide
AU2359301A (en) Novel ss-defensins
AU1881200A (en) Novel proteins
AU2002216100A1 (en) Dormancy - induced mycobacterium proteins
AU2061201A (en) Mammalian dishevelled-associated proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU6983000A (en) Chimeric proteins
AU2002224357A1 (en) Mammalian wnt polypeptide-5
AU6567400A (en) Substituted 2-imino-thiazolines
AU2001297949A1 (en) Mammalian alpha-helical protein-53
AU2002344252A1 (en) Mammalian diabetes-mediating proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase